Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies

Steven Simoens^1*David Dodwell²Michael Hartevelt³Peter Lindgren^4,5Michele Pistollato⁶Lisa G Pont⁷Caridad Pontes⁸Alexander Roediger³Antun Sablek⁹Eric Van Ganse¹⁰Qinyi Wang¹¹Chris Wenger¹²Tim Wilsdon⁶Entela Xoxi¹³Brian Godman^14,15

• ¹KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium
• ²Oxford Population Health, University of Oxford, Oxford, United Kingdom
• ³Global Oncology Policy, Merck, Rahway, NJ, United States
• ⁴Swedish Institute for Health Economics, Lund, Sweden
• ⁵Health Economics, Karolinska Institute, Solna, Sweden
• ⁶Charles River Associates, London, United Kingdom
• ⁷Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia
• ⁸Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, Barcelona, Spain
• ⁹Charles River Associates, Brussels, Belgium
• ¹⁰Pharmacoepidemiology Unit, Claude Bernard University Lyon 1, Lyon, France
• ¹¹Charles River Associates, Cambridge, United Kingdom
• ¹²Aquantic AG, Zeiningen, Switzerland
• ¹³Postgraduate School of Health Economics and Management (ALTEMS), Catholic University of the Sacred Heart, Rome, Italy
• ¹⁴Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
• ¹⁵Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa

Frontiers' correction template for authors A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval. Instructions: ● Please read through all the templates before choosing ● Pick the most relevant text template(s) from the following page and delete all others. ● Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. ● Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary ● Submit to Frontiers following the instructions on this page. When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example: There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake. The original version of this article has been updated. In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).'' Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies Name of all authors as they appear in the published original article (INSERT ONLY IF correcting author names or adding authors. Insert the correct version of the author list) Affiliations of all authors as they appear in the published original version of the article (INSERT ONLY IF correcting affiliation(s) or adding affiliation(s). Insert the correct version of the affiliation(s)) * Correspondence: email of the corresponding author from the original version of the article Keywords: same as original article Correction on: full citation of the original version of the article. Author affiliation Erroneously assigned Removing: Author Entela Xoxi [insert author name] was erroneously assigned to affiliation Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom [insert incorrect affiliation]. This affiliation has now been removed for author Entela Xoxi [insert author name]. The conflict of interest statement has been correct to Entela Xoxi [insert correct COI]. The original version of this article has been updated.